AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

KONTROLMATİK TEKNOLOJİ ENERJİ VE MÜHENDİSLİK A.Ş.

Share Issue/Capital Change Aug 9, 2024

5935_rns_2024-08-09_326be89a-1c56-422a-b1ef-56400804d0d0.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

Summary Info Explanation on the Date and Method of Sale of Unused Pre-emptive Rights
Update Notification Flag Yes
Correction Notification Flag No
Postponed Notification Flag No
Board Decision Date 28.12.2023
Authorized Capital (TL) 750.000.000
Paid-in Capital (TL) 200.000.000
Target Capital (TL) 650.000.000

Bonus Issue

Share Group Info Paid-in Capital (TL) Amount of Bonus Issue From Internal Resources (TL) Rate of Bonus Issue From Internal Resources (%) Amount of Bonus Issue From Dividend (TL) Rate of Bonus Issue From Dividend (%) Share Group Issued New Shares'' ISIN Nevi
KONTR, TREKNTR00013 200.000.000 250.000.000,000 125,00000 KONTR, TREKNTR00013 Registered
Paid-in Capital (TL) Amount of Bonus Issue From Internal Resources (TL) Rate of Bonus Issue From Internal Resources (%) Amount of Bonus Issue From Dividend (TL) Rate of Bonus Issue From Dividend (%)
TOTAL 200.000.000 250.000.000,000 125,00000
Bonus Issue Ex-Date 19.07.2024

Details of Internal Resources :

Other Profit Reserves (TL) 250.000.000

Rights Issue (Via Preemptive Right)

Share Group Info Paid-in Capital (TL) Preemptive Rights Amount (TL) Preemptive Rights Rate (%) Preemptive Rights Price Share Group Issued New Shares'' ISIN Form Preemptive Rights ISIN Code Unused Rights Amount (TL) Amount of Shares Cancelled (TL)
KONTR, TREKNTR00013 200.000.000 200.000.000,000 100,00000 1,00 KONTR, TREKNTR00013 Registered KONTR(RÜÇHAN), TRRKNTR00015 318.892,609
Paid-in Capital (TL) Preemptive Rights Amount (TL) Preemptive Rights Rate (%) Unused Rights Amount (TL) Amount of Shares Cancelled (TL)
TOTAL 200.000.000 200.000.000,000 100,00000 318.892,609
Explanation About The Shares Not Sold Not available
Rights Issue Ex-Date 19.07.2024
Preemptive Rights Exercise End Date 02.08.2024
Currency Unit TRY

Other Aspects To Be Notified

Number of Articles of Association Item To Be Amended 6
Capital Market Board Application Date Regarding Articles of Association 24.01.2024
Capital Market Board Application Date 24.01.2024
Capital Market Board Application Result Approval
Capital Market Board Approval Date 11.07.2024
Property of Increased Capital Shares Dematerialized Share
Payment Date 23.07.2024
Record Date 22.07.2024

Additional Explanations

Within the registered capital ceiling of 750,000,000 TL, our company's capital increase of 200,000,000 TL, which is fully covered with a cash contribution at a rate of 100% and 250,000,000 TL from internal resources at a rate of 125%, making a total increase of 450,000,000 TL at a rate of 225%, has been approved by the Capital Markets Board in its meeting dated 11/07/2024, and published in the CMB bulletin numbered 2024/32 on 11/07/2024.

The rights to purchase new shares were provided for 15 days between 19.07.2024 and 02.08.2024 in accordance with the principles specified in the prospectus.

The total nominal value of the remaining shares after the exercise of preemptive rights is 318,892.609 TL.

The remaining shares will be offered for sale at the price that will be formed in the Borsa Istanbul A.Ş. Primary Market, not below their nominal value of 1 TL per share, through Bizim Menkul Değerler A.Ş. between 15.08.2024 and 16.08.2024, for 2 business days.

There is no commitment to purchase the portion that remains unsubscribed after the exercise of preemptive rights and the public offering.

The announcement containing the public offering principles can also be accessed from the websites of the Public Disclosure Platform (KAP) at www.kap.org.tr, our company at www.kontrolmatik.com, and Bizim Menkul Değerler A.Ş., which will mediate the sale in the public offering, at www.bmd.com.tr.

Turkish and English translations of this statement are available, and in case of any conflict between them, the Turkish version will prevail.

Talk to a Data Expert

Have a question? We'll get back to you promptly.